(2022) Article PubMed Google Scholar Related article Perreault, L
If the break is less than four weeks, many providers recommend resuming at the same dose you were previously taking
The main exception to this rule is the GLP-1 class (like semaglutide, tirzepatide, or retatrutide), which may be used for longer under proper supervision since the studies and pharmacology support extended duration
PMID: 35658024 Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M
Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in This week, a seven-person FDA advisory committee will spend two days deciding the fate of peptides my patients have been asking about for over a year
Pituitary 27:685692 Poston L, Caleyachetty R, Cnattingius S et al (2016) Preconceptional and maternal obesity: epidemiology and health consequences